They provide researchers tools to probe the architecture of the human brain. Using fMRI and psychs could help map different areas of the brain. Inward into the human psyche is the new frontier.

I would assume if a psychedelic gets approved from a major regulatory authority (e.g., FDA, EMEA, etc) for an indication, that would resolve as "yes"?

Not necessarily. If it's just a psychological benefit, even as extreme as making peace with death, that's still individual and subjective, right?

I mean no regulatory authority is going to approve that as an indication since that’s not a disease

Treatment of any well-defined and generally recognized medical condition would count. Treatments already known, such as cannabis for glaucoma and nausea, or psilocybin for cluster headaches, would not count.

@Quroe

Market resolves in or about 30 days, by consensus.

can you say more about the resolution? what consensus?

@Slackhammer bump^